Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Articles with KFF Health News and NBC News referenced a commentary published in the April 2025 issue of The American Journal of Managed Care® (AJMC®). The commentary, “Prior Authorizations and the Adverse Impact on Continuity of Care,” focused on how the current process for prior authorizations can have negative impacts on patient care, which has led to practices switching to a cash-only business model.
An article from Moneywise referenced an article published on AJMC.com, the website of AJMC. The article, “Survey Exposes Pervasive Billing Errors, Aggressive Tactics in US Health Insurance,” covered the results of a report that revealed that 45% of adults with insurance received a medical bill for a service that they thought was covered and 17% were denied coverage for a service that was recommended by a physician.
In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel
June 24th 2025In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in challenging cases.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More